HIV I Infection Clinical Trial
Official title:
Intervention to Improve HIV Care Retention and Antiretroviral Adherence in Stigmatized Environments
Retention in care and persistent adherence to antiretroviral therapy are necessary for the successful treatment of HIV infection. HIV-related stigma is a known impediment to the care and health outcomes of people living with HIV. The proposed study will test theory-based interventions designed to manage HIV stigma in order to improve care retention and medication adherence in communities with high-levels of HIV-related stigma.
This trial is conducting a randomized test of a behavioral self-management intervention designed to improve HIV treatment outcomes in people living with HIV in stigmatized contexts. The trial includes a control arm and a non-stigma enhanced treatment adherence intervention arm. Participants living in an economically under-resourced area of South Africa are recruited through clinical care settings. The goal of the research is to examine whether directly addressing HIV stigma and medication adherence management improves treatment outcomes beyond those observed from a standard behavioral intervention without added stigma-addressing components. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04585737 -
Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF
|
Phase 4 | |
| Not yet recruiting |
NCT06282783 -
Studying Topiramate for Re-Activating the HIV-1 Reservoir
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT03622177 -
Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection
|
||
| Recruiting |
NCT05854381 -
To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV
|
Phase 1 | |
| Enrolling by invitation |
NCT05071378 -
Leveraging Family-Based Assets for Black MSM In House Ball Communities
|
N/A | |
| Completed |
NCT05421806 -
A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/
|
||
| Completed |
NCT04568395 -
Acute Effects of TCIG vs ECIG in PLWH
|
N/A | |
| Recruiting |
NCT04887675 -
Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI
|
N/A | |
| Recruiting |
NCT04820933 -
Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV
|
Early Phase 1 | |
| Completed |
NCT03584048 -
Charlotte Retention in Care Study
|
||
| Recruiting |
NCT06005610 -
Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy
|
Phase 2 | |
| Recruiting |
NCT05947890 -
Evaluating the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South Africa
|
Phase 2 | |
| Recruiting |
NCT05187429 -
Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT05601128 -
A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA
|
Phase 3 | |
| Completed |
NCT04675255 -
Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism
|
N/A | |
| Completed |
NCT03986099 -
Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART
|
N/A | |
| Completed |
NCT04971343 -
Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol
|
||
| Completed |
NCT04725877 -
VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04618198 -
Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa
|
Phase 3 | |
| Completed |
NCT05383456 -
The Visceral Adiposity Measurement and Observation Study
|